Q-Line Biotech Peer Comparison

NSE: QLINE

₹535.00

₹18.45 (3.57%)

As on 11-Nov-2026 10:54IST

Market cap

₹1,205 Cr

Revenue (TTM)

₹342 Cr

P/E Ratio

21.6

P/B Ratio

2.5

Div. Yield

0 %

Edit

	Q-Line Biotech	Poly Medicure	Saakshi Medtech	QMS Medical	Nureca
Market cap (₹ Cr)	1,205	16,372	737	329	293
Revenue (₹ Cr)	342	2,134	116	183	174
Net Profit (₹ Cr)	55.72	309.79	12.29	12.72	4.76
Net Margin (%)	16.04	13.89	10.59	6.90	2.64
RoE (%)	25.55	9.92	11.80	10.39	2.58
Price to Earnings	21.63	51.42	60.00	30.25	61.49
Price-To-Book	2.47	5.01	4.85	--	1.56

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Q-Line Biotech	Poly Medicure	Saakshi Medtech	QMS Medical	Nureca
Operating Revenue	341.74	1,875.26	115.51	152.30	146.96
Total Income	347.44	2,002.19	116.04	152.65	155.06
Total Expenditure	243.64	1,436.66	93.29	131.80	146.78
EBITDA	98.10	438.59	22.22	20.50	0.18
Depreciation	10.79	115.52	4.74	3.51	2.02
EBIT	87.31	323.08	17.48	16.99	-1.84
Interest	19.47	21.42	1.35	7.89	1.28
Other Income	5.70	126.93	0.54	0.35	8.10
Exceptional Items	-0.99	-6.80	--	--	--
Profit before Tax	72.55	427.47	16.67	9.45	4.98
Provision for Tax	16.83	106.74	4.38	2.76	2.90
Profit after Tax	55.72	320.73	12.29	6.69	2.08

Liabilities (₹ Cr)

	Q-Line Biotech	Poly Medicure	Saakshi Medtech	QMS Medical	Nureca
Shareholder's Funds	246.19	3,106.17	110.33	104.22	180.76
Minority Interest	--	43.07	--	--	--
Non-Current Liabilities	101.51	120.16	16.71	24.01	-0.92
Current Liabilities	209.92	666.53	29.82	91.76	13.78
Total Liabilities	558.69	3,951.60	156.99	220.04	196.16

Assets (₹ Cr)

	Q-Line Biotech	Poly Medicure	Saakshi Medtech	QMS Medical	Nureca
Non-Current Assets	213.57	1,903.19	95.54	89.33	78.94
Current Assets	344.06	2,032.74	61.32	130.66	114.68
Total Assets	558.69	3,951.60	156.99	220.04	196.16
Total Debt*	225.48	341.62	25.45	90.92	0.72
Net Current Assets	134.14	1,366.21	31.50	38.91	100.90
Contingent Liabilities	52.55	50.21	5.27	1.05	4.73

Cashflow (₹ Cr)

	Q-Line Biotech	Poly Medicure	Saakshi Medtech	QMS Medical	Nureca
Cash From Operating Activities	16.38	246.37	--	18.77	3.30
Cash Flow from Investing Activities	-29.42	-225.38	--	-18.27	14.49
Cash from Financing Activities	41.64	20.15	--	-0.78	-19.56
Net Cash Inflow / Outflow	28.60	41.14	0.00	-0.28	-1.77

Ratios

Profitability Ratios

	Q-Line Biotech	Poly Medicure	Saakshi Medtech	QMS Medical	Nureca
ROCE (%)	22.23	14.05	14.32	9.62	3.31
ROE (%)	25.55	10.94	11.80	6.96	1.11
ROA (%)	11.01	8.89	8.54	3.27	1.04
EBIT Margin (%)	30.37	30.16	19.70	13.69	5.63
Net Margin (%)	16.04	16.02	10.59	4.38	1.34
Cash Profit Margin (%)	18.40	23.12	12.56	6.70	2.57

Growth Ratios

	Q-Line Biotech	Poly Medicure	Saakshi Medtech	QMS Medical	Nureca
Revenue Growth (%)	9.13	12.30	24.96	5.13	34.02
EBIT Growth (%)	40.81	3.80	109.09	-12.29	69.11
Net Profit Growth (%)	255.32	-5.27	160.94	-35.79	145.86
EPS Growth (%)	180.69	-4.88	160.94	-40.73	157.91
Book Value Growth (%)	29.61	12.14	12.53	18.37	-6.96

Valuation Ratios

	Q-Line Biotech	Poly Medicure	Saakshi Medtech	QMS Medical	Nureca
Price / Earnings	0.00	37.47	25.29	20.81	94.46
Price / Book Value	0.00	3.90	2.82	1.34	1.09
Dividend Yield (%)	--	0.29	0.00	0.69	0.00
EV/EBITDA	1.59	21.79	14.69	11.03	18.84
Market Cap (₹ Cr)	0.00	12,069.92	310.75	139.23	196.67

Solvency Ratios

	Q-Line Biotech	Poly Medicure	Saakshi Medtech	QMS Medical	Nureca
Debt to Equity	0.92	0.11	0.23	0.87	0.00
Short term debt to equity ratio	0.36	0.08	0.03	0.60	0.00
Current Ratio	1.64	3.05	2.06	1.42	8.32
Quick Ratio	1.19	2.40	1.34	0.92	4.88
Interest Coverage	4.73	20.96	13.37	2.20	4.88

Operating Efficiency Ratios

	Q-Line Biotech	Poly Medicure	Saakshi Medtech	QMS Medical	Nureca
Debtors to sales (%)	36.82	28.33	22.72	38.85	5.27
Asset Turnover	0.71	0.52	0.94	0.74	0.80
Receivable days	105.22	85.20	64.80	135.40	12.70
Inventory Days	93.48	69.58	56.27	102.09	100.27
Payable days	146.52	77.97	52.79	71.73	22.92
Cash Conversion Cycle	52.17	76.82	68.27	165.75	90.04